VCU Massey now uses bioimpedance spectroscopy for early lymphedema detection in breast cancer patients, enabling noninvasive screening, earlier intervention, and improved long-term outcomes.

FDA approved a dual agent eye drop for presbyopia, offering adults over 40 improved near vision, reduced reliance on reading glasses, and expanded treatment options.

An international survey reveals current practices and gaps in primary urethral cancer care, guiding earlier diagnosis, treatments, and collaborative strategies to improve outcomes for patients.

Understanding normal testosterone ranges helps identify hormone imbalances affecting mood, energy, and health, guiding testing, diagnosis, and informed treatment decisions for men and women.

Elevated allergy-related immune markers in seborrheic dermatitis suggest a possible allergic component, prompting reconsideration of disease mechanisms and treatment approaches while causality remains under investigation.

Advanced robotic knee-ankle prostheses improve coordination and joint function, enabling amputees to perform demanding daily activities with more natural movement, independence, and improved quality of life.

Retinal imaging reveals microvascular changes in patients with obstructive sleep apnea, highlighting links between sleep disorders and eye health, and emphasizing the importance of early ophthalmic screening.

Rising early labor inductions before 39 weeks are prompting scrutiny of maternal and neonatal safety, challenging obstetric guidelines and decision-making for mothers and care teams.

Emerging real-world data are shaping debates on GLP-1 receptor agonists’ effectiveness and safety, influencing weight and metabolic care decisions for patients and clinicians managing diabetes and obesity.

FDA approval extends etonogestrel implant use to five years, offering sustained 99% efficacy, fewer visits, lower costs, and improved access to long-acting contraception for women.